On the public citation graph
GADRP: graph convolutional networks and autoencoders for cancer drug response prediction
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 75 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1002/ijc.23610 (notice 2016-08-18).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.23610openalex-snapshotRetracted: TW‐37, a small‐molecule inhibitor of Bcl‐2, inhibits cell growth and invasion in pancreatic cancer
inferredcites →https://doi.org/10.1016/j.bbrc.2017.01.140openalex-snapshotAnthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition
inferredcites →https://doi.org/10.1038/srep32679openalex-snapshotInferences of drug responses in cancer cells from cancer genomic features and compound chemical and therapeutic properties
inferredcites →https://doi.org/10.1093/bib/bbab165openalex-snapshotMDA-GCNFTG: identifying miRNA-disease associations based on graph convolutional networks via graph sampling through the feature and topology graph
inferredcites →https://doi.org/10.1093/nar/gks1111openalex-snapshotGenomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
inferredcites →https://doi.org/10.1093/neuonc/nov083openalex-snapshotPhase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
inferredcites →https://doi.org/10.3322/caac.21660openalex-snapshotGlobal Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
inferredcites →https://doi.org/10.5732/cjc.011.10290openalex-snapshotNiclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1093/bib/bbae242openalex-snapshotA comprehensive benchmarking of machine learning algorithms and dimensionality reduction methods for drug sensitivity prediction
inferred← citeshttps://doi.org/10.1093/bib/bbag225openalex-snapshotFoundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation
inferred← citeshttps://doi.org/10.3389/fbinf.2026.1838904openalex-snapshotBCheM: a framework integrating molecular attributes and behavioral representations for precise prediction of drug resistance across multiple disease contexts
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.